Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

43.50 -0.51 (-1.16%)
Streaming Delayed Price Updated: 9:31 AM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
LivaNova to Announce Third-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
 
Via Benzinga
The Latest Analyst Ratings for LivaNova
 
Via Benzinga
LivaNova Earnings Preview
 
Via Benzinga
Looking Into LivaNova's Return On Capital Employed
 
Via Benzinga
Recap: LivaNova Q1 Earnings
 
Via Benzinga
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Baird Global Healthcare Conference
From LivaNova PLC
Via Business Wire
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
Alphabet, Boeing, Union Pacific And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
LivaNova Reports Second-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
 
Via Benzinga
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
From LivaNova PLC
Via Business Wire
LivaNova Reports First-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
LivaNova Board of Directors Announce Leadership Changes
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
 
Via Benzinga
LivaNova to Announce First-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova Launches SenTiva DUO
From LivaNova PLC
Via Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
 
Via Benzinga
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
From LivaNova PLC
Via Business Wire
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
From LivaNova PLC
Via Business Wire
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
From LivaNova PLC
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.